e-ISSN: Pending
Negative / Null Result ReportOpen accessDiseases of the endocrine glands. Clinical endocrinology

Lack of effect of Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12 on beta-cell function in children with newly diagnosed type 1 diabetes: a randomised controlled trial

Hania Szajewska; Agnieszka Szypowska; Lidia Groele; Mieczysław Szalecki; Jolanta Świderska; Marta Wysocka-Mincewicz; Agnieszka Ochocińska; Anna Stelmaszczyk-Emmel · 2021 · BMJ Open Diabetes Research & Care

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Introduction The gut microbiota may be relevant in the development of type 1 diabetes (T1D). We examined the effects of Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12 on beta-cell function in children with newly diagnosed T1D.Research design and methods Children aged 8–17 years with newly (within 60 days) diagnosed T1D were enrolled in a double-blind, randomised controlled trial in which they received L. rhamnosus GG and B. lactis Bb12 at a dose of 109 colony-forming units or placebo, orally, once daily, for 6 months. The follow-up was for 12 months. The primary outcome measure was

Abstract by Hania Szajewska; Agnieszka Szypowska; Lidia Groele; Mieczysław Szalecki; Jolanta Świderska; Marta Wysocka-Mincewicz; Agnieszka Ochocińska; Anna Stelmaszczyk-Emmel, BMJ Open Diabetes Research & Care (2021) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1136/bmjdrc-2020-001523